首页> 外文期刊>Saudi Journal of Biological Sciences >Anticancer activities of selected Emirati Date (Phoenix dactylifera L.) varieties pits in human triple negative breast cancer MDA-MB-231 cells
【24h】

Anticancer activities of selected Emirati Date (Phoenix dactylifera L.) varieties pits in human triple negative breast cancer MDA-MB-231 cells

机译:选定的Emirati日期(Phoenix Dactylifera L)的抗癌活动在人类三重阴性乳腺癌MDA-MB-231细胞中的品种凹坑

获取原文
获取外文期刊封面目录资料

摘要

The date palm ( Phoenix dactylifera L.) is an important fruit crop with significant pharmaceutical potential. Little data are available on comparative pharmaceutical importance of the date pits. We designed this study to assess the antitumorigenic effects of date palm pits extracts from different Emiratis varieties. We used MDA-MB-231 cells derived from triple negative breasts cancer tissues as a model. We found that out of the 17 date pits extracts from 6 Emiratis varieties, three (Khalas extract in water?+?acetone (1:1), Abu-Maan extract in MeOH?+?Chloroform (1:1) and Mabroom extract in water?+?acetone (1:1)) were found effectively cytotoxic and changed morphology of cells in dose and time dependent manner. We found the maximum effect at 2.5?mg/mL concentration at 72?h. We calculated IC50 values for these varieties at 24?h. IC50 values for Khalas, Abu-Maan and Mabroom were 0.982?mg/mL, 1.149?mg/mL and 2.213?mg/mL respectively. We treated the cells with IC50 values of extracts and observed changes in protein profile using human kinase array kit. After analyzing the results, we suggest that EGFR/ERK/FAK pathway, eNOS and src family proteins are targets of these extracts. We conclude that date pits extracts can be a possible therapeutic agent against cancer and we suggest further studies.
机译:Date Palm(Phoenix Dactylifera L)是具有重要药物潜力的重要果实作物。少数数据可以在日期坑的比较制药中提供。我们设计了本研究,以评估枣棕榈坑提取物的抗肿瘤效果来自不同的埃及品种。我们使用从三重阴性乳房癌组织的MDA-MB-231细胞作为模型。我们发现,从6个竞争品种的17个日期坑中提取物,三个(哈拉斯提取物在水中?+?丙酮(1:1),在MeOH的Abu-Maan提取物中α+?氯仿(1:1)和摩客提取物有效地发现了水?+ +丙酮(1:1))细胞毒性,并以剂量​​和时间依赖性方式改变细胞形态。我们发现在72℃下为2.5?mg / ml浓度的最大效果。我们在24℃下计算了这些品种的IC50值。 Khalas,Abu-Maan和Mabroom的IC 50值分别为0.982Ω·mg / ml,1.149?mg / ml和2.213Ωmg/ ml。我们用IC 50的提取物对细胞进行处理,并使用人类激酶阵列试剂盒观察蛋白质谱的变化。在分析结果后,我们建议EGFR / ERK / FAK途径,ENOS和SRC系列蛋白是这些提取物的靶标。我们得出结论,日期坑提取物可以是可能的治疗剂免受癌症,我们建议进一步研究。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号